• 1
    Beasley R, Crane J, Lai CK, et al. Prevalence and etiology of asthma. J Allergy Clin Immunol 2000;105 (2 Pt 2):S46672.
  • 2
    Gleich GJ & Jacob GL. Immunoglobulin E antibodies to pollen allergens account for high percentages of total immunoglobulin E protein. Science 1975;190:11061108.
  • 3
    Coyle AJ, Wagner K, Bertrand C, et al. Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody. J Exp Med 1996;183:13031310.
  • 4
    Solley GO, Gleich GJ, Jordon RE, et al. The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest 1976;58:408420.
  • 5
    Gleich GJ, Jacoby DB, Fryer AD. Eosinophil-associated inflammation in bronchial asthma: a connection to the nervous system [Review]. Int Arch Allergy Immunol 1995;107:205207.
  • 6
    Gundel RH, Letts LG, Gleich GJ. Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J Clin Invest 1991;87:14701473.
  • 7
    White SR, Ohno S, Munoz NM, et al. Epithelium-dependent contraction of airway smooth muscle caused by eosinophil MBP. Am J Physiol 1990;259:L294L303.
  • 8
    Barnes PJ. Pathophysiology of allergic inflammation. In: MiddletonEJ, EllisE, YungingerJ, ReedC, AdkinsonNJr, BusseW, editors. Allergy: principles and practice. 5th ed. St Louis, Mo: Mosby, 1998:356365.
  • 9
    Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996;383:787793.
  • 10
    Corry DB & Kheradmand F. Induction and regulation of the IgE response. Nature 1999;402:B18B23.
  • 11
    O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998;8:275283.
  • 12
    Nakajima H, Iwamoto I, Tomoe S, et al. CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am Rev Respir Dis 1992;146:374377.
  • 13
    Brusselle G, Kips J, Joos G, et al. Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. Am J Res Cell Mol Biol 1995;12:254259.
  • 14
    Coyle AJ, Le Gros G, Bertrand C, et al. Interleukin-4 is required for the induction of lung Th2 mucosal immunity. Am J Res Cell Mol Biol 1995;13:5459.
  • 15
    Robinson DS, Hamid Q, Ying S, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298304.
  • 16
    Gavett SH, O'Hearn DJ, Li X, et al. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 1995;182:15271536.
  • 17
    Iwamoto I, Kumano K, Kasai M, Kurasawa K, Nakao A. Interleukin-12 prevents antigen-induced eosinophil recruitment into mouse airways. Am J Respir Crit Care Med 1996;154:12571260.
  • 18
    Kips JC, Brusselle GJ, Joos GF, et al. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice. Am J Respir Crit Care Med 1996;153:535539.
  • 19
    Nakajima H, Iwamoto I, Yoshida S. Aerosolized recombinant interferon-gamma prevents antigen-induced eosinophil recruitment in mouse trachea. Am Rev Res Dis 1993;148:11021104.
  • 20
    Sur S, Lam J, Bouchard P, et al. Immunomodulatory effects of IL-12 on allergic lung inflammation depend on timing of doses. J Immunol 1996;157:41734180.
  • 21
    Shaheen SO, Aaby P, Hall AJ, et al. Measles and atopy in Guinea-Bissau. Lancet 1996;347:17921796.
  • 22
    Shirakawa T, Enomoto T, Shimazu S, et al. The inverse association between tuberculin responses and atopic disorder. Science 1997;275:7779.DOI: 10.1126/science.275.5296.77
  • 23
    Jarvis D, Chinn S, Luczynska C, et al. The association of family size with atopy and atopic disease. Clin Exp Allergy 1997;27:240245.
  • 24
    Strachan DP. Family size, infection and atopy: the first decade of the “hygiene hypothesis”. Thorax 2000;55 Suppl 1:210.
  • 25
    Ball TM, Castro-Rodriguez JA, Griffith KA, et al. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med 2000;343:538543.
  • 26
    Tokunaga T, Yamamoto H, Shimada S, et al. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J Nat Cancer Inst 1984;72:955962.
  • 27
    Tokunaga T, Yamamoto S, Namba K. A synthetic single-stranded DNA, poly(dG,dC), induces interferon-alpha/beta and -gamma, augments natural killer activity, and suppresses tumor growth. Jpn J Cancer Res 1988;79:682686.
  • 28
    Yamamoto S, Kuramoto E, Shimada S, et al. In vitro augmentation of natural killer cell activity and production of interferon-alpha/beta and -gamma with deoxyribonucleic acid fraction from Mycobacterium bovis BCG. Jpn J Cancer Res 1988;79:866873.
  • 29
    Yamamoto S, Yamamoto T, Shimada S, et al. DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol Immunol 1992;36:983997.
  • 30
    Yamamoto S, Yamamoto T, Kataoka T, et al. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J Immunol 1992;148:40724076.
  • 31
    Krieg AM, Yi AK, Matson S, et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995;374:546549.
  • 32
    Heeg K & Zimmermann S. CpG DNA as a Th1 trigger [Review]. Int Arch Allergy Immunol 2000;121:8797.
  • 33
    Van Uden J & Raz E. Immunostimulatory DNA and applications to allergic disease. J Allergy Clin Immunol 1999;104:902910.
  • 34
    Ballas ZK, Rasmussen WL, Krieg AM. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol 1996;157:18401845.
  • 35
    Klinman DM, Yamshchikov G, Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol 1997;158:36353639.
  • 36
    Kuramoto E, Yano O, Kimura Y, et al. Oligonucleotide sequences required for natural killer cell activation. Jpn J Cancer Res 1992;83:11281131.
  • 37
    Stacey KJ, Sweet MJ, Hume DA. Macrophages ingest and are activated by bacterial DNA. J Immunol 1996;157:21162122.
  • 38
    Bird AP. DNA methylation and the frequency of CpG in animal DNA. Nucleic Acids Res 1980;8:14991504.
  • 39
    Burge C, Campbell AM, Karlin S. Over- and under-representation of short oligonucleotides in DNA sequences. Proc Nat Acad Sci U S A 1992;89:13581362.
  • 40
    Karlin S, Doerfler W, Cardon LR. Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses? J Virol 1994;68:28892897.
  • 41
    Sun S, Kishimoto H, Sprent J. DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen. J Exp Med 1998;187:11451150.
  • 42
    Bird AP, Taggart MH, Nicholls RD, et al. Non-methylated CpG-rich islands at the human alpha-globin locus: implications for evolution of the alpha-globin pseudogene. EMBO J 1987;6:9991004.
  • 43
    Hacker H, Mischak H, Miethke T, et al. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J 1998;17:62306240.DOI: 10.1093/emboj/17.21.6230
  • 44
    Krieg AM, Gmelig-Meyling F, Gourley MF, et al. Uptake of oligodeoxyribonucleotides by lymphoid cells is heterogeneous and inducible. Antisense Res Dev 1991;1:161171.
  • 45
    Zhao Q, Song X, Waldschmidt T, et al. Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activation. Blood 1996;88:17881795.
  • 46
    Krieg AM, Tonkinson J, Matson S, et al. Modification of antisense phosphodiester oligodeoxynucleotides by a 5′ cholesteryl moiety increases cellular association and improves efficacy. Proc Nat Acad Sci U S A 1993;90:10481052.
  • 47
    Zhao Q, Matson S, Herrera CJ, et al. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res Dev 1993;3:5366.
  • 48
    Macfarlane DE & Manzel L. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds. J Immunol 1998;160:11221131.
  • 49
    Krieg AM, Hartmann G, Yi AK. Mechanism of action of CpG DNA [Review]. Curr Top Microbiol Immunol 2000;247:121.
  • 50
    Chu W, Gong X, Li Z, et al. DNA-PKcs is required for activation of innate immunity by immuno-stimulatory DNA. Cell 2000;103:909918.
  • 51
    Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000;408:740745.DOI: 10.1038/35047123
  • 52
    Schnare M, Holtdagger AC, Takeda K, et al. Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88. Curr Biol 2000;10:11391142.DOI: 10.1016/s0960-9822(00)00700-4
  • 53
    Hacker H, Vabulas RM, Takeuchi O, et al. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J Exp Med 2000;192:595600.
  • 54
    Hacker H, Mischak H, Miethke T, et al. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J 1998;17:62306240.DOI: 10.1093/emboj/17.21.6230
  • 55
    Hacker H, Mischak H, Hacker G, et al. Cell type-specific activation of mitogen-activated protein kinases by CpG-DNA controls interleukin-12 release from antigen-presenting cells. EMBO J 1999;18:69736982.DOI: 10.1093/emboj/18.24.6973
  • 56
    Yi AK & Krieg AM. Cutting edge – rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA. J Immunol 1998;161:44934497.
  • 57
    Underwood DC, Osborn RR, Kotzer CJ, et al. SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. J Pharmacol Exp Ther 2000;293:281288.
  • 58
    Sparwasser T, Miethke T, Lipford G, et al. Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock. Eur J Immunol 1997;27:16711679.
  • 59
    Sweet MJ, Stacey KJ, Ross IL, et al. Involvement of Ets, Rel and Sp1-like proteins in lipopolysaccharide-mediated activation of the HIV-1 LTR in macrophages. J Inflamm 1998;48:6783.
  • 60
    Yi AK & Krieg AM. CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of I kappa B alpha and I kappa B beta and sustained activation of nuclear factor-kappa B/c-Rel. J Immunol 1998;160:12401245.
  • 61
    Yi AK, Klinman DM, Martin TL, et al. Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J Immunol 1996;157:53945402.
  • 62
    Yi AK, Tuetken R, Redford T, et al. CpG motifs in bacterial DNA activate leukocytes through the Ph-dependent generation of reactive oxygen species. J Immunol 1998;160:47554761.
  • 63
    Halpern MD, Kurlander RJ, Pisetsky DS. Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha. Cell Immunol 1996;167:7278.DOI: 10.1006/cimm.1996.0009
  • 64
    Roman M, Martin-Orozco E, Goodman JS, et al. Immuno-stimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 1997;3:849854.
  • 65
    Schwartz DA, Quinn TJ, Thorne PS, et al. CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract. J Clin Invest 1997;100:6873.
  • 66
    Sun S, Zhang X, Tough DF, et al. Type I interferon-mediated stimulation of T cells by CpG DNA. J Exp Med 1998;188:23352342.
  • 67
    Yi AK, Klinman DM, Martin TL, et al. Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J Immunol 1996;157:53945402.
  • 68
    Zhao Q, Temsamani J, Zhou RZ, et al. Pattern and kinetics of cytokine production following administration of phosphorothioate oligonucleotides in mice. Antisense Nucleic Acid Drug Dev 1997;7:495502.
  • 69
    Roman M, Martin-Orozco E, Goodman JS, et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 1997;3:849854.
  • 70
    Sato Y, Roman M, Tighe H, et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 1996;273:352354.
  • 71
    Chace JH, Hooker NA, Mildenstein KL, et al. Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12. Clin Immunol Immunopathol 1997;84:185193.DOI: 10.1006/clin.1997.4380
  • 72
    Martin-Orozco E. Enhancement of antigen-presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences. Int Immunol 1999;11:11111118.DOI: 10.1093/intimm/11.7.1111
  • 73
    Banchereau J & Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245252.DOI: 10.1038/32588
  • 74
    Hartmann G, Weiner GJ, Krieg AM. CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc Natl Acad Sci U S A 1999;96:93059310.
  • 75
    Sparwasser T, Koch ES, Vabulas RM, et al. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur J Immunol 1998;28:20452054.DOI: 10.1002/(sici)1521-4141(199806)28:06<2045::aid-immu2045>;2-#
  • 76
    Redford TW, Yi AK, Ward CT, et al. Cyclosporin A enhances IL-12 production by CpG motifs in bacterial DNA and synthetic oligodeoxynucleo-tides. J Immunol 1998;161:39303935.
  • 77
    Klinman DM, Yi AK, Beaucage SL, et al. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Nat Acad Sci U S A 1996;93:28792883.
  • 78
    Halpern MD, Kurlander RJ, Pisetsky DS. Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha. Cell Immunol 1996;167:7278.DOI: 10.1006/cimm.1996.0009
  • 79
    Yi AK, Chace JH, Cowdery JS, et al. IFN-gamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleo-tides. J Immunol 1996;156:558564.
  • 80
    Yi AK, Hornbeck P, Lafrenz DE, et al. CpG DNA rescue of murine b lym-phoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-x(l). J Immunol 1996;157:49184925.
  • 81
    Yi AK, Chang M, Peckham DW, et al. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J Immunol 1998;160:58985906.
  • 82
    Yi AK, Peckham DW, Ashman RF, et al. CpG DNA rescues B cells from apoptosis by activating NFkappaB and preventing mitochondrial membrane potential disruption via a chloroquine-sensitive pathway. Int Immunol 1999;11:20152024.DOI: 10.1093/intimm/11.12.2015
  • 83
    Liang H & Lipsky PE. Responses of human B cells to DNA and phosphorothioate oligodeoxy-nucleotides. Curr Top Microbiol Immunol 2000;247:227240.
  • 84
    Liang H, Nishioka Y, Reich CF, et al. Activation of human B cells by phosphorothioate oligodeoxynucleo-tides. J Clin Invest 1996;98:11191129.
  • 85
    Korsgren M, Persson CG, Sundler F, et al. Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J Exp Med 1999;189:553562.
  • 86
    Cowdery JS, Chace JH, Yi AK, et al. Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. J Immunol 1996;156:45704575.
  • 87
    Kranzer K, Bauer M, Lipford GB, et al. CpG-oligodeoxynucleotides enhance T-cell receptor-triggered interferon-gamma production and up-regulation of CD69 via induction of antigen-presenting cell-derived interferon type I and interleukin-12. Immunology 2000;99:170178.DOI: 10.1046/j.1365-2567.2000.00964.x
  • 88
    Hsu CH, Chua KY, Tao MH, et al. Inhibition of specific IgE response in vivo by allergen-gene transfer. Int Immunol 1996;8:14051411.
  • 89
    Hsu CH, Chua KY, Tao MH, et al. Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nat Med 1996;2:540544.
  • 90
    Lee DJ, Tighe H, Corr M, et al. Inhibition of IgE antibody formation by plasmid DNA immunization is mediated by both CD4+ and CD8+ T cells. Int Arch Allergy Immunol 1997;113:227230.
  • 91
    Kline JN, Waldschmidt TJ, Businga TR, et al. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J Immunol 1998;160:25552559.
  • 92
    Sur S, Wild JS, Choudhury BK, et al. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxy-nucleotides. J Immunol 1999;162:62846293.
  • 93
    Shirota H, Sano K, Kikuchi T, et al. Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxy-nucleotides as a novel antigen-specific immunomodulator. J Immunol 2000;164:55755582.
  • 94
    Jahn-Schmid B, Wiedermann U, Bohle B, et al. Oligodeoxynucleotides containing CpG motifs modulate the allergic TH2 response of BALB/c mice to Bet v 1, the major birch pollen allergen. J Allergy Clin Immunol 1999;104:10151023.
  • 95
    Shirota H, Sano K, Kikuchi T, et al. Regulation of T-helper type 2 cell and airway eosinophilia by transmucosal coadministration of antigen and oligodeoxynucleotides containing CpG motifs. Am J Respir Cell Mol Biol 2000;22:176182.
  • 96
    Spiegelberg HL, Tighe H, Roman M, et al. Inhibition of IgE formation and allergic inflammation by allergen gene immunization and by CpG motif immunostimulatory oligodeoxy-nucleotides. Allergy 1998;53:9397.
  • 97
    Spiegelberg HL, Broide D, Tighe H, et al. Inhibition of allergic inflammation in the lung by plasmid DNA allergen immunization. Pediatr Pulmonol Suppl 1999;18:118121.
  • 98
    Broide D, Schwarze J, Tighe H, et al. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J Immunol 1998;161:70547062.
  • 99
    Mueller HL & Lanz M. Hyposensitization with bacterial vaccine in infectious asthma. A double-blind study and a longitudinal study. JAMA 1969;208:13791383.
  • 100
    Hartl A, Kiesslich J, Weiss R, et al. Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen. J Allergy Clin Immunol 1999;103:107113.
  • 101
    Tighe H, Takabayashi K, Schwartz D, et al. Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol 2000;106:124134.
  • 102
    Magone MT, Chan CC, Beck L, et al. Systemic or mucosal administration of immunostimulatory DNA inhibits early and late phases of murine allergic conjunctivitis. Eur J Immunol 2000;30:18411850.DOI: 10.1002/1521-4141(200007)30:7<1841::aid-immu1841>;2-e
  • 103
    Kline JN, Krieg AM, Waldschmidt TJ, et al. CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma. J Allergy Clin Immunol 1999;104:12581264.
  • 104
    Chiaramonte MG, Hesse M, Cheever AW, et al. CpG oligonucleotides can prophylactically immunize against Th2-mediated schistosome egg-induced pathology by an IL-12-independent mechanism. J Immunol 2000;164:973985.
  • 105
    Campbell E, Kunkel SL, Strieter RM, et al. Differential roles of IL-18 in allergic airway disease: induction of eotaxin by resident cell populations exacerbates eosinophil accumulation. J Immunol 2000;164:10961102.
  • 106
    Kumano K, Nakao A, Nakajima H, et al. Interleukin-18 enhances antigen-induced eosinophil recruitment into the mouse airways. Am J Respir Crit Care Med 1999;160:873878.
  • 107
    Wild JS, Sigounas A, Sur N, et al. IFN-gamma-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma. J Immunol 2000;164:27012710.
  • 108
    Bohle B, Jahn-Schmid B, Maurer D, et al. Oligodeoxynucleotides containing CpG motifs induce IL-12, IL-18 and IFN-gamma production in cells from allergic individuals and inhibit IgE synthesis in vitro. Eur J Immunol 1999;29:23442353.DOI: 10.1002/(sici)1521-4141(199907)29:07<2344::aid-immu2344>;2-r
  • 109
    Parronchi P, Brugnolo F, Annunziato F, et al. Phosphorothioate oligodeoxynucleotides promote the in vitro development of human allergen-specific CD4+ T cells into Th1 effectors. J Immunol 1999;163:59465953.
  • 110
    Fujieda S, Iho S, Kimura Y, et al. Synthetic oligodeoxynucleotides inhibit IgE induction in human lymphocytes. Am J Respir Crit Care Med 2000;162:232239.
  • 111
    Creticos PS, Eiden JJ, Balcer SL, et al. Immunostimulatory oligonucleotides conjugated to Amb a 1: safety, skin test reactivity, and basophil histamine release. J Allergy Clin Immunol 2000;105:A215.
  • 112
    Schwartz DA, Wohlford-Lenane CL, Quinn TJ, et al. Bacterial DNA or oligonucleotides containing unmethylated CpG motifs can minimize lipopolysaccharide-induced inflammation in the lower respiratory tract through an IL-12-dependent pathway. J Immunol 1999;163:224231.
  • 113
    Sparwasser T, Miethke T, Lipford G, et al. Bacterial DNA causes septic shock. Nature 1997;386:336337.
  • 114
    Gilkeson GS, Grudier JP, Karounos DG, et al. Induction of anti-double-stranded DNA antibodies in normal mice by immunization with bacterial DNA. J Immunol 1989;142:14821486.
  • 115
    Gilkeson GS, Ruiz P, Howell D, et al. Induction of immune-mediated glomerulonephritis in normal mice immunized with bacterial DNA. Clin Immunol Immunopathol 1993;68:283292.DOI: 10.1006/clin.1993.1129
  • 116
    Deng GM & Tarkowski A. The role of bacterial DNA in septic arthritis. Int J Mol Med 2000;6:2933.
  • 117
    Vallin H, Perers A, Alm GV, et al. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. J Immunol 1999;163:63066313.
  • 118
    Krapf F, Herrmann M, Leitmann W, et al. Antibody binding of macromolecular DNA and RNA in the plasma of SLE patients. Clin Exp Immunol 1989;75:336342.
  • 119
    Richardson B, Scheinbart L, Strahler J, et al. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1990;33:16651673.
  • 120
    Sano H, Takai O, Harata N, et al. Binding properties of human anti-DNA antibodies to cloned human DNA fragments. Scand J Immunol 1989;30:5163.
  • 121
    Sur S, Lam J, Choudhury BK, et al. Mucosal IL-12 is more effective than systemic IL-12 in upregulating IFN-γ expression and inhibiting allergic lung eosinophilia. Exp Lung Res 2000;26:457476.DOI: 10.1080/01902140050130365
  • 122
    Sur S, Bouchard P, Holbert D, et al. Mucosal IL-12 is more effective than systemic IL-12 in inhibiting airway reactivity to methacholine and ventilatory failure in murine asthma. Exp Lung Res 2000;26:477489.DOI: 10.1080/01902140050130374
  • 123
    Schwarze J, Hamelmann E, Cieslewicz G, et al. Local treatment with IL-12 is an effective inhibitor of airway hyperresponsiveness and lung eosinophilia after airway challenge in sensitized mice. J Allergy Clin Immunol 1998;102:8693.
  • 124
    Choudhury BK, Wild JS, Mileski J, et al. Internalization of CpG DNA by alveolar macrophages rapidly phosphorylates p38 MAP kinase and induces IFN-γ, IL-12 mRNA expression and IL-18 production. J Allergy Clin Immunol 2000;105:A489.
  • 125
    Cookson WO & Moffatt MF. Alchemy for asthma. Nat Med 1988;4:500501.